ArticleDiagnostics (Basel, Switzerland)2025
Preliminary Evidence for a Western Blot Diagnosis of Satoyoshi Syndrome Using SH-SY5Y Neuroblastoma Cell Lysate as the Antigen Source.
José María Sevilla Avendaño, Carlos Garrido, Irene Rodríguez Clemente, Julián Solís-García Del Pozo, Ulrich Stephani, Ricardo Martínez, Carlos de Cabo, Valentín Ceña, Javier Solera
Abstract read
In one paragraphArticle in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
José María Sevilla AvendañoNeuropsychopharmacology Unit, Research Department, Complejo Hospitalario Universitario de Albacete, 02008 Albacete, Spain.
Carlos GarridoNeuropsychopharmacology Unit, Research Department, Complejo Hospitalario Universitario de Albacete, 02008 Albacete, Spain.
Irene Rodríguez ClementeUnidad Asociada Neurodeath, Institute of Molecular Nanoscience, INAMOL, Universidad de Castilla-La Mancha, 02008 Albacete, Spain.
Julián Solís-García Del PozoImmunological, Molecular, and Genetic Bases of Satoyoshi Syndrome Group, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), 45004 Toledo, Spain.
Ulrich StephaniKlinik für Neonatologie, Kinderpneumologie und Neuropädiatrie (Kinder und Jugendmedizin II), University Hospital of Schleswig Holstein (UKSH), Campus of Kiel, 24118 Kiel, Germany.
Ricardo MartínezDepartment of Oral and Maxillofacial Surgery, Hospital Universitario de Canarias, 38320 La Laguna, Spain.ORCID 0000-0001-5955-6490 Carlos de CaboNeuropsychopharmacology Unit, Research Department, Complejo Hospitalario Universitario de Albacete, 02008 Albacete, Spain.ORCID 0000-0002-2144-0107 Valentín CeñaUnidad Asociada Neurodeath, Institute of Molecular Nanoscience, INAMOL, Universidad de Castilla-La Mancha, 02008 Albacete, Spain.
Javier SoleraImmunological, Molecular, and Genetic Bases of Satoyoshi Syndrome Group, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), 45004 Toledo, Spain.
Funding
Diputación Provincial de Albacete 33501, 2021Research Commission of the Albacete General University Hospital, Spain 2015 Call
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
autoantibodiesautoimmunebiomarkersdiagnosisrare diseasesSatoyoshi syndromeSH-SY5YWestern blot
Identifiers
PMID41226088
PMCPMC12610766
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390